Awareness of doctors and epilepsy patients about preferential drug provision
https://doi.org/10.17749/2077-8333/epi.par.con.2023.143
Abstract
Background. Drug support provided to the general population and medical institutions represents one of the most important directions in social policy of the Russian Federation.
Objective. To determine the awareness epileptologists and epilepsy patients about legal normative and regulatory aspects regarding preferential drug provision (PDP).
Material and methods. The study was conducted by using empirical data retrieved from questionnaire survey of epilepsy patients and epileptologists. We used an original questionnaire that consisted of questions about the PDP legal normative and regulatory aspects as well as organization of drug provision for patients with epilepsy.
Results. The study data revealed that half of the surveyed patients were unaware of the legal right to have a reduced drug coverage for patients with epilepsy without disability. The normative document designating the categories of diseases including epilepsy as well as the level of appropriate drug coverage for which citizens may qualif, was unknown to either patients or health care workers. Both groups named no the authorized body to which they should apply in case of refusal obtain a preferential vacation leave. The minimum number of correct answers was received to the questions about the maximum term of course prescriptions for reduced-price supply, the term of service for such prescriptions as well as the term for submission of notice on unwanted response to Federal Service for Surveillance in Healthcare (Roszdravnadzor). One-third of patients were unaware of the opportunity for electronic appeal to a state health care authority.
Conclusion. There is a need for educational activities among health care professionals and patient outreach to increase awareness of own legal rights and responsibilities of participants of PDP for epilepsy patients.
About the Authors
A. S. Romanov
Altai State Medical University
Russian Federation
Russian Federation
Anton S. Romanov – Postgraduate, Chair of Pharmacy
40 Lenin Ave., Barnaul 656038
E. F. Sharakhova
Altai State Medical University
Russian Federation
Russian Federation
Elena F. Sharakhova – Dr. Pharm. Sc., Professor, Chief of Chair of Pharmacy
40 Lenin Ave., Barnaul 656038
N. I. Shova
Bekhterev National Medical Research Centre for Psychiatry and Neurology
Russian Federation
Russian Federation
Natalia I. Shova – MD, PhD, Researcher, Department for Treatment of Patients with Exogenous Organic Disorders and Epilepsy
WoS ResearcherID: AAI-3755-2020; Scopus Author ID: 57215893698
3 Bekhterev Str., Saint Petersburg 192019
V. A. Mikhailov
Bekhterev National Medical Research Centre for Psychiatry and Neurology
Russian Federation
Russian Federation
Vladimir A. Mikhailov – Dr. Med. Sc., Chief Researcher, Scientific Supervisor, Department for Treatment of Patients with Exogenous Organic Disorders and Epilepsy, Department for Integrative Therapy of Patients of Neuropsychiatric Profile
WoS ResearcherID: B-3272-2017
3 Bekhterev Str., Saint Petersburg 192019
References
1. Human security now: protecting and empowering people / Commission on Human Security. 2003. Available at: https://digitallibrary.un.org/record/503749?ln=es (accessed 01.09.2022).
2. Resolution adopted by the Human Rights Council on 1 July 2016 – 32/15. Access to medicines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health. Available at: https://www.refworld.org.ru/pdfid/57e918db4.pdf (in Russ.) (accessed 01.09.2022).
3. Mironova T.K. The right for medicinal help and provision. Voprosy Rossiyskogo i mezhdunarodnogo prava / Issues of Russian and International Law. 2016; 5: 97–112 (in Russ.).
4. Kopilevich V.V. A project of the socially oriented budget-insurance model for financing the medicine provision in Russia. Problems of Governance. 2012; 4 (7): 88–98 (in Russ.).
5. Petrukhina I.K., Ryazanova T.K., Khusainova A.I., et al. Evaluation of the implementation of regional programs of preferential drug provision for patients suffering from mental illnesses, schizophrenia. Modern Organization of Drug Supply. 2021; 8 (1): 100–3 (in Russ.). https://doi.org/10.30809/solo.4.2020.22.
6. Lepakhin V.K., Romanov B.K., Toropova I.A. The analysis of reports on adverse drug reactions. Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation. 2012; 1: 22–5 (in Russ.).
7. Khoseva E.N., Morozova T.E., Andrushchishina T.B. Efficacy and safety of modern medicines in the prism of opinion of patients. Klinicheskaya farmakologiya i terapiya / Clinical Pharmacology and Therapy. 2012; 21 (1): 30–4 (in Russ.).
8. Federal Law of 17.07.1999 No. 178-FZ “On state social assistance”. Available at: https://base.garant.ru/180687/ (in Russ.) (accessed 01.09.2022).
9. Federal Law of 13.07.2020 No. 206-FZ “On amendments to certain legislative acts of the Russian Federation on the provision of medicines, medical devices and specialized medical nutrition products to citizens”. Available at: https://base.garant.ru/74369768/ (in Russ.) (accessed 01.09.2022).
10. Decree of the Government of the RF of 30.07.1994 No. 890 “On state support for the development of the medical industry and improving the provision of medicines and medical products to the population and healthcare institutions”. Available at: https://base.garant.ru/101268/ (in Russ.) (accessed 01.09.2022).
11. Federal Law of 21.11.2011 No. 323-FZ “On the basics of public health protection in the Russian Federation”. Available at: https://base.garant.ru/12191967/ (in Russ.) (accessed 01.09.2022).
12. Federal Law of 02.05.2006 No. 59-FZ “On the procedure for considering appeals of citizens of the Russian Federation”. Available at: https://base.garant.ru/12146661/ (in Russ.) (accessed 01.09.2022).
13. Order of the Ministry of Health of the RF of 11.07.2017 No. 403n “On approval of the rules for the release of medicines for medical use, including immunobiological medicines, by pharmacy organizations, individual entrepreneurs licensed for pharmaceutical activities”. Available at: https://www.garant.ru/products/ipo/prime/doc/71659682/ (in Russ.) (accessed 01.09.2022).
14. Definition of the Judicial Board for Civil Cases of the Supreme Court of the RF of 10.09.2018 No. 57-GK18-13. Available at: https://www.consultant.ru/cons/cgi/online.cgi?req=doc&base=ARB&n=555993#sWsqkfT46qkBnsPA (in Russ.) (accessed 01.09.2022).
15. Decree of the Government of the RF of 03.08.2021 No. 1297 “On approval of the Regulations on state control (supervision) over the implementation by executive authorities of the subjects of the Russian Federation of powers in the field of health protection and state control (supervision) over the implementation by local selfgovernment authorities of powers in the field of health protection”. Available at: https://base.garant.ru/401587260/ (in Russ.) (accessed 01.09.2022).
Review
For citations:
Romanov A.S., Sharakhova E.F., Shova N.I., Mikhailov V.A. Awareness of doctors and epilepsy patients about preferential drug provision. Epilepsy and paroxysmal conditions. 2023;15(2):107-114. (In Russ.) https://doi.org/10.17749/2077-8333/epi.par.con.2023.143
Views:
1265
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
